Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

Dai, Mengyuan, Liu, Dianbo, Liu, Miao, Zhou, Fuxiang, Li, Guiling, Chen, Zhen, Zhang, Zhian, You, Hua +30 more·2020·Cancer Discovery
DOI 10.1158/2159-8290.cd-20-0422

Cited by (1,001)

Items 201–300 of 1,001

  1. Association Between Androgen Deprivation Therapy and Mortality Among Patients With Prostate Cancer and COVID-19
    Andrew Lachlan Schmidt, Matthew D. Tucker, Ziad Bakouny, Chris Labaki, Chih–Yuan Hsu, Yu Shyr, Andrew J. Armstrong, Tomasz M. Beer, Ragneel R. Bijjula, Mehmet Asım Bilen et al. · 2021 · JAMA Network Open
  2. Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience
    Nalinie Joharatnam‐Hogan, Daniel Hochhauser, Kai‐Keen Shiu, Hannah L. Rush, Valerie Elizabeth Crolley, William Wilson, Anand Sharma, Aun Muhammad, Muhammad Naveed Anwar, Nikhil Vasdev et al. · 2020 · Therapeutic Advances in Medical Oncology
  3. Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper
    Tim Cooksley, Carme Font, Florian Scotté, Carmen P. Escalante, Leslie C. M. Johnson, Ronald Anderson, Bernardo Leon Rapoport · 2020 · Supportive Care in Cancer
  4. Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward
    Kush Gupta, Shipra Gandhi, Alexander Mebane, Angelica Singh, Nivetha Vishnuvardhan, Eshan U. Patel · 2020 · Cancer Treatment and Research Communications
  5. Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center
    Gisele Aparecida Fernandes, Diego Feriani, Ivan Leonardo Avelino França e Silva, Diego Rodrigues Mendonça e Silva, Paola Engelmann Arantes, Juliana da Silva Canteras, Rodrigo Reghini da Silva, María Paula Curado · 2021 · Seminars in Oncology
  6. Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
    Arielle Elkrief, Julie Tsu-Yu Wu, Chinmay Jani, Kyle T. Enriquez, Michael J. Glover, Mansi R. Shah, Hira Ghazal Shaikh, Alicia C. Beeghly-Fadiel, Benjamin C. French, Sachin R. Jhawar et al. · 2021 · Cancer Discovery
  7. COVID‐19 outcomes in hospitalized patients with active cancer: Experiences from a major New York City health care system
    Chen Fu, James Hart Stoeckle, Lena S. Masri, Abhishek Pandey, Meng Cao, Dalia Littman, Marissa Danielle Rybstein, Sunil E. Saith, Kinan Yarta, Abhinav Rohatgi et al. · 2021 · Cancer
  8. Antecedent immunosuppressive therapy for immune-mediated inflammatory diseases in the setting of a COVID-19 outbreak
    Jesse J. Veenstra, Connor R. Buechler, Gabrielle Robinson, Stephanie Chapman, Madeline J. Adelman, Aaron Tisack, Peter Michael Dimitrion, Erika Todter, Laurie Linden Kohen, Henry W. Lim · 2020 · Journal of the American Academy of Dermatology
  9. Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement
    Daniel John Lenihan, Joseph R. Carver, Charles Porter, Jennifer E. Liu, Susan Faye Dent, Paaladinesh Thavendiranathan, Joshua D. Mitchell, Anju Nohria, Michael G. Fradley, Iskra Pusic et al. · 2020 · CA A Cancer Journal for Clinicians
  10. COVID-19 mortality in cancer patients: a report from a tertiary cancer centre in India
    Anurag Mehta, Smreti Vasudevan, Anuj Parkash, Anurag Sharma, Tanu Vashist, Vidya Krishna · 2021 · PeerJ
  11. Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19
    Jiewen Fu, Chunli Wei, Jiayue He, Lianmei Zhang, Ju Zhou, Kyathegowdanadoddi Srinivasa Balaji, Shiyi Shen, Jiangzhou Peng, Amrish Sharma, Junjiang Fu · 2021 · International Journal of Biological Sciences
  12. COVID and Lung Cancer
    Luana Calabrò, Giulia Rossi, Alessia Covre, Aldo Morra, Michele Maio · 2021 · Current Oncology Reports
  13. Challenges posed by COVID‐19 in cancer patients: A narrative review
    Zeinab Mohseni Afshar, Rezvan Hosseinzadeh, Mohammad Barary, Soheil Ebrahimpour, Amirmasoud Alijanpour, Babak Sayad, Dariush Hosseinzadeh, Seyed Rouhollah Miri, Terence Tai Weng Sio, Mark J. M. Sullman et al. · 2021 · Cancer Medicine
  14. Comorbidities and mortality rate in COVID‐19 patients with hematological malignancies: A systematic review and meta‐analysis
    Adel Naimi, Ilya Yashmi, Reza Jebeleh, Mohammad Imani Mofrad, Shakiba Azimian Abhar, Yasaman Jannesar, Mohsen Heidary, Reza Pakzad · 2022 · Journal of Clinical Laboratory Analysis
  15. Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology
    Catherine Allison Stewart, Carl Michael Gay, Kavya Ramkumar, Kasey R. Cargill, Robert J. Cardnell, Monique B. Nilsson, Simon Heeke, Elizabeth M. Park, Samrat T. Kundu, Lixia Diao et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  16. COVID-19 and cancer: do we really know what we think we know?
    Andrew George Robinson, Bishal Gyawali, Gerald A. Evans · 2020 · Nature Reviews Clinical Oncology
  17. ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
    Melanie Engler, Dan Albers, Pascal von Maltitz, Rüdiger M. Groß, Jan Münch, Ion Cristian Cirstea · 2023 · Life Science Alliance
  18. Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges
    Alessandro Allegra, Giovanni Pioggia, Alessandro Tonacci, Caterina Musolino, Sebastiano Gangemi · 2020 · Cancers
  19. Haematological cancers and the risk of severe COVID‐19: Exploration and critical evaluation of the evidence to date
    Dima El‐Sharkawi, Sunil Iyengar · 2020 · British Journal of Haematology
  20. Immunometabolic Status of COVID-19 Cancer Patients
    Antonio Sica, Mario P. Colombo, Annalisa Trama, Leora Horn, Marina Chiara Garassino, Valter Torri · 2020 · Physiological Reviews
  21. Susceptibility to Coronavirus (COVID-19) in Occupational Settings: The Complex Interplay between Individual and Workplace Factors
    Veruscka Leso, Luca Fontana, Ivo Iavicoli · 2021 · International Journal of Environmental Research and Public Health
  22. Higher mortality in lung cancer patients with COVID-19? A systematic review and meta-analysis
    Haike Lei, Yue Yang, Wei Zhou, Mengyang Zhang, Yang Shen, Dan Tao, Lulu Wang, Qianqian Lei, Ying Wang, Yongzhong Wu · 2021 · Lung Cancer
  23. COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review
    Valentina Bonuomo, Isacco Ferrarini, Michele Dell’Eva, Eugenio Sbisà, Mauro Krampera, Carlo Visco · 2021 · World Journal of Virology
  24. COVID-19 Pandemic: Impact on Cancer Patients
    Monika Rucińska, Sergiusz Nawrocki · 2022 · International Journal of Environmental Research and Public Health
  25. Behavioral and psychosocial responses of people receiving treatment for advanced lung cancer during the <scp>COVID</scp>‐19 pandemic: A qualitative analysis
    Hyland, Kelly A., Jim, Heather S.L. · 2020 · Psycho-Oncology
  26. Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance
    Meredith Leston, Willam Elson, José Manuel Ordóñez-Mena, Debasish Kar, Heather Whitaker, Mark Joy, Nia Wyn Roberts, Richard F. Hobbs, Simon de Lusignan · 2024 · Journal of Infection
  27. Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid
    Antonio Calles, Inmaculada Aparicio, Manuel Alva, M. Bringas Beranek, Natalia Gutiérrez, Javier Andrés Soto, Marta Arregui, Victoria Clara Tirado, Enrique L. Álvarez, Marı́a del Monte-Millán et al. · 2020 · Frontiers in Oncology
  28. The Risk and Prevalence of COVID-19 Infection in Colorectal Cancer Patients: a Systematic Review and Meta-analysis
    Mohammad Hossein Antikchi, Hossein Neámatzadeh, Yaser Ghelmani, Jamal Jafari Nedooshan, Seyed Alireza Dastgheib, Shadi Kargar, Mahmood Noorishadkam, Reza Bahrami, Mohammad Hossein Jarahzadeh · 2020 · Journal of Gastrointestinal Cancer
  29. Facts and Hopes in Multiple Myeloma Immunotherapy
    Adam Samuel Sperling, Kenneth Carl Anderson · 2021 · Clinical Cancer Research
  30. Cumulative COVID ‐19 incidence, mortality and prognosis in cancer survivors: A population‐based study in Reggio Emilia, Northern Italy
    Lucìa Mangone, Francesco Paolo Gioia, Pamela Mancuso, Isabella Bisceglia, Marta Ottone, Massimo Vicentini, Carmine Pinto, Paolo Giorgi Rossi · 2021 · International Journal of Cancer
  31. Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection
    Nader Yatim, Jérémy Boussier, Pauline Tétu, Nikaïa Smith, Timothée Bruel, Bruno Charbit, Laura Barnabei, Aurélien Corneau, Laetitia Da Meda, Clara Allayous et al. · 2021 · Science Advances
  32. Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency
    Jonas S. Heitmann, Claudia Tandler, Maddalena Marconato, Annika Nelde, Timorshah Habibzada, Susanne Malaika Rittig, Christian Martin Tegeler, Yacine Maringer, Simon U. Jaeger, Monika Denk et al. · 2023 · Nature Communications
  33. Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease
    Anusha Shirwaikar Thomas, Stephen B. Hanauer, Yinghong Wang · 2022 · Clinical Gastroenterology and Hepatology
  34. Deciphering the Relationship between SARS-CoV-2 and Cancer
    Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni Nicola Roviello · 2023 · International Journal of Molecular Sciences
  35. Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis
    Robin Park, Anusha Chidharla, Kathan Dilipbhai Mehta, Weijing Sun, Elizabeth Marie Wulff-Burchfield, Anup Kasi · 2020 · EClinicalMedicine
  36. Changes in Lung Cancer Treatment as a Result of the Coronavirus Disease 2019 Pandemic
    Arielle Elkrief, Suzanne Kazandjian, Nathaniel Bouganim · 2020 · JAMA Oncology
  37. SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
    Mark Howell, Ryan J. Green, Andrew R. McGill, Rinku Dutta, Subhra Mohapatra, Shyam S. Mohapatra · 2021 · Cancers
  38. An epigenome‐wide DNA methylation study of patients with COVID‐19
    Shengyu Zhou, Jintao Zhang, Jiawei Xu, Fayan Zhang, Peng Li, Yujie He, Julong Wu, Chunting Wang, Ximing Wang, Wei Zhang et al. · 2021 · Annals of Human Genetics
  39. COVID-19: Safe Guidelines for Breast Imaging During the Pandemic
    Jean Morag Seely, Anabel M. Scaranelo, Charlotte Jane Yong-Hing, Shusheila Appavoo, Carolyn Flegg, Supriya R. Kulkarni, Anat Kornecki, Nancy A. T. Wadden, Yves Loisel, Stephanie C. Schofield et al. · 2020 · Canadian Association of Radiologists Journal
  40. Assessing the Impact of COVID-19 on the Clinical Trial Objective and Analysis of Oncology Clinical Trials—Application of the Estimand Framework
    Evgeny Degtyarev, Kaspar Rufibach, Yue Shentu, Godwin Yung, Michelle Casey, Stefan Englert, Feng Liu, Yi Liu, Oliver Sailer, Jonathan Siegel et al. · 2020 · Statistics in Biopharmaceutical Research
  41. Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer
    Vasileios Angelis, Zayd Tippu, Kroopa Joshi, Sara Reis, Firza Alexander Gronthoud, Charlotte Victoria Fribbens, Alicia F. C. Okines, Susannah Jane Stanway, Emma Cottier, Sophie McGrath et al. · 2020 · European Journal of Cancer
  42. Cancer increases risk of in-hospital death from COVID-19 in persons <65 years and those not in complete remission
    Qiubai Li, Lei Chen, Qin Li, Wenjuan He, Jianming Yu, Li Chen, Yulin Cao, Wenlan Chen, Di Wu, Fang Dong et al. · 2020 · Leukemia
  43. SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis
    Gaurav Seth, Saira Sethi, Shristi Bhattarai, Geetanjali Saini, Chandra Bhushan Singh, Ritu Aneja · 2020 · Cancers
  44. Mortality of patients with COVID ‐19 who undergo an elective or emergency surgical procedure: a systematic review and meta‐analysis
    Wendy A. Brown, Eileen M. Moore, David Allan Watters · 2020 · ANZ Journal of Surgery
  45. Prediction of Severity of COVID-19-Infected Patients Using Machine Learning Techniques
    Aziz Alotaibi, Mohammad Shiblee, Adel Alshahrani · 2021 · Computers
  46. Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
    Laura Mansi, Laurie Spehner, Étienne Daguindau, Kévin Bouiller, Hamadi Almotlak, Ulrich Stein, Adeline Bouard, Stefano Chong Hun Kim, Élodie Klajer, Marine Jary et al. · 2021 · European Journal of Cancer
  47. Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis
    Nicole J. Hardy, Charan Thej Reddy Vegivinti, Mansi Mehta, Jade Thurnham, Alexander Mebane, John Michael Pederson, Ranita Tarchand, Jeevan Shivakumar, Peace Olaniran, Ritika Gadodia et al. · 2023 · Clinical and Experimental Medicine
  48. Seroprevalence of SARS-CoV-2–specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data
    Luis Cabezón‐Gutiérrez, Sara Custodio‐Cabello, Magda Palka-Kotlowska, Eduardo Oliveros Acebes, María José García Navarro, Parham Khosravi‐Shahi · 2020 · Cancer Treatment Reviews
  49. Do COVID-19–Related Treatment Changes Influence Fear of Cancer Recurrence, Anxiety, and Depression in Breast Cancer Patients?
    Soo Yeon Kim, Sue Kim · 2021 · Cancer Nursing
  50. Covid‐19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany
    Khalid Shoumariyeh, Francesca Biavasco, Gabriele Ihorst, Siegbert Rieg, Alexandra Nieters, Winfried V. Kern, Cornelius Miething, Justus Duyster, Monika Martha Engelhardt, Hartmut Bertz · 2020 · Cancer Medicine
  51. Use of a Remote Oncology Pharmacy Service Platform for Patients With Cancer During the COVID-19 Pandemic: Implementation and User Acceptance Evaluation
    Zhuojia Chen, Weiting Liang, Qing Liu, Rong He, Qian-Chao Chen, Qiu-Feng Li, Yao Zhang, Xiao-Dong Du, Ying Pan, Shu Liu et al. · 2020 · Journal of Medical Internet Research
  52. COVID‐19 infection in children with cancer and stem cell transplant recipients in Turkey: A nationwide study
    Rejin Kebudi, Nilgün Kurucu, Deniz Tuğcu, Şadan Hacısalihoğlu, Tunç Fışgın, Süheyla Ocak, Gülnür Tokuç, Nihal Özdemir, Ceyhun Bozkurt, Dilek İnce et al. · 2021 · Pediatric Blood & Cancer
  53. The Deadly Duo of COVID-19 and Cancer!
    Vivek R. Bora, Bhoomika M. Patel · 2021 · Frontiers in Molecular Biosciences
  54. SARS-COV-2 infection and lung tumor microenvironment
    Naila Malkani, Muhammad Usman Rashid · 2021 · Molecular Biology Reports
  55. Indications for and Contraindications of Immune Checkpoint Inhibitors in Cancer Patients with COVID-19 Vaccination
    Bangyu Luo, Jixi Li, Xianhua Hou, Qiao Yang, Yi Zhou, Jun Ye, Xiao‐Cheng Wu, Yimei Feng, Tianyu Hu, Zhi Zhong Xu et al. · 2021 · Future Oncology
  56. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
    Matthew D. Galsky, Arjun Vasant Balar, Peter C. Black, Matthew T. Campbell, Gail Dykstra, Petros D. Grivas, Shilpa Gupta, Christoper J Hoimes, Lidia López, Joshua J. Meeks et al. · 2021 · Journal for ImmunoTherapy of Cancer
  57. Immune-Guided Therapy of COVID-19
    Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, Stefania Canè, Vincenzo Bronte · 2022 · Cancer Immunology Research
  58. Patient‐reported disruptions to cancer care during the COVID ‐19 pandemic: A national cross‐sectional study
    Jacob J. Lang, Aparna Narendrula, Sharanya Iyer, Kristine M. Zanotti, Puneet Sindhwani, Elias A. Mossialos, Obi Ekwenna · 2022 · Cancer Medicine
  59. SARS-CoV-2 infection as a potential risk factor for the development of cancer
    Natalia Ogarek, Paulina Oboza, Magdalena Olszanecka‐Glinianowicz, Piotr Kocełak · 2023 · Frontiers in Molecular Biosciences
  60. A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?
    Maryam Joudi, Maryam Moradi Binabaj, Pejman Porouhan, Babak PeyroShabany, Mohsen Tabasi, Danial Fazilat‐Panah, Mahtab Khajeh, Arezoo Mehrabian, Mansoureh Dehghani, James S. Welsh et al. · 2022 · Frontiers in Endocrinology
  61. Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma
    Zachary Wright, Adrian Reyes Bersabe, Rina Eden, Jessica Bradley, Andrew Cap · 2020 · Clinical Lymphoma Myeloma & Leukemia
  62. Discordance of COVID‐19 guidelines for patients with cancer: A systematic review
    Pankaj Kumar Garg, Pallvi Kaul, Deepti Choudhary, Kiran Kalyan Turaga, Mahendra Pal Singh, Ajeet Ramamani Tiwari, Vipin Arora, Nishant Agrawal, Beat Rau, Sai Yendamuri · 2020 · Journal of Surgical Oncology
  63. Cardio‐Oncology in the Era of the COVID‐19 Pandemic and Beyond
    Daniel Addison, Courtney M. Campbell, Avirup Guha, Arjun Kumar Ghosh, Susan Faye Dent, Hani M. Jneid · 2020 · Journal of the American Heart Association
  64. Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months
    Begoña de las Heras, Kamal S. Saini, Frances M. Boyle, Felipe Ades, Evandro de Azambuja, Ivana Božović‐Spasojević, Marco Romano, Marta Capelán, Rajeev Prasad, Pugazhenthi Pattu et al. · 2020 · Oncology and Therapy
  65. Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
    Georgios Chamilos, Michail S. Lionakis, Dimitrios P. Kontoyiannis · 2020 · Clinical Infectious Diseases
  66. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and “New Old Friends”
    Thomas O. Kleen, Alicia A. Galdon, Andrew S. MacDonald, Angus George Dalgleish · 2020 · Frontiers in Immunology
  67. SARS‐CoV‐2 infection among patients with haematological disorders: Severity and one‐month outcome in 66 Danish patients in a nationwide cohort study
    Andreas Birkedal Glenthøj, Lasse Hjort Jakobsen, Henrik Sengeløv, Syed Arif Ahmad, Kristian Qvist, Annika Rewes, Christian Bjørn Poulsen, Ulrik Malthe Overgaard, Ingolf Mølle, Marianne Tang Severinsen et al. · 2020 · European Journal Of Haematology
  68. Immunological alternation in COVID-19 patients with cancer and its implications on mortality
    Guangyao Cai, Yue Gao, Shaoqing Zeng, Yang Yu, Xingyu Liu, Dan Liu, Ya Wang, Ruidi Yu, Aakash P. Desai, Chunrui Li et al. · 2021 · OncoImmunology
  69. Determinants of Health and Physical Activity Levels Among Breast Cancer Survivors During the COVID-19 Pandemic: A Cross-Sectional Study
    Aline Rachel Bezerra Gurgel, Pedro Mingroni-Netto, Jose Carlos Farah, Christina May Moran de Brito, Anna Sara Levin, Patrı́cia C. Brum · 2021 · Frontiers in Physiology
  70. Risk perception, treatment adherence, and personality during COVID‐19 pandemic: An international study on cancer patients
    Simone Cheli, Wwt Lam, Tania Estapé, Jeanette Winterling, Ozan Bahçivan, Elisabeth Andritsch, Joachim Weis, Isabel Centeno, Samantha Serpentini, Clemens Farkas et al. · 2021 · Psycho-Oncology
  71. Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)
    Yingshuang Li, Hua-Cheng Ren, Jian-Hua Cao · 2022 · International Journal of Oncology
  72. Immunizing the imperfect immune system
    Jessica R. Durkee-Shock, Michael Daniel Keller · 2022 · Annals of Allergy Asthma & Immunology
  73. Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma
    Hira S. Mian, Shakira Jeanene Grant, Monika Martha Engelhardt, Charlotte Pawlyn, Sara Bringhen, Sonja Zweegman, Claudia A.M. Stege, Ashley Elizabeth Rosko, Marie von Lilienfeld‐Toal, Tanya Marya Wildes · 2020 · Journal of Geriatric Oncology
  74. Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic
    Serena Zuliani, Ilaria Zampiva, Daniela Tregnago, Miriam Casali, Alessandro Cavaliere, Arianna Fumagalli, Sara Merler, Silvia Teresa Riva, Alice Rossi, Francesca Zacchi et al. · 2020 · European Journal of Cancer
  75. FDG-PET/CT images of COVID-19: a comprehensive review
    Ryogo Minamimoto, Masatoshi Hotta, Masahiro Ishikane, Takeshi Inagaki · 2020 · Global Health & Medicine
  76. SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients
    Vincenzo Quagliariello, Annamaria Bonelli, Antonietta Caronna, Gabriele Conforti, Martina Iovine, Andreina Carbone, Massimiliano Berretta, Gerardo Botti, Nicola Maurea · 2020 · Cancers
  77. Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial
    Margriet Vreugdenhil, Charles Fong, Paul Sanghera, Andrew G. J. Hartley, Janet Dunn, Hisham Mohamed Mehanna · 2020 · Oral Oncology
  78. Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea
    Marc Boutros, Elissar Moujaess, Hampig Raphaël Kourié · 2021 · Critical Reviews in Oncology/Hematology
  79. COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary
    Thomas Round, Veline L’Esperance, Joanne Bayly, Kate E. Brain, Lorraine Dallas, John G. Edwards, Thomas Haswell, Crispin T. Hiley, Natasha Lovell, Julia McAdam et al. · 2021 · British Journal of Cancer
  80. Vaccination of cancer patients against COVID-19: towards the end of a dilemma
    Avik Mandal, Pritanjali Singh, Arghadip Samaddar, Dharmendra Pratap Singh, Manika Verma, Amrita Rakesh, Rakesh Ranjan · 2021 · Medical Oncology
  81. Characterizing cancer and COVID-19 outcomes using electronic health records
    Youngran Kim, Liang Zhu, Huili Zhu, Xiaojin Li, Yan Huang, Chunhui Gu, Heather Bush, Caroline D. Chung, Guo‐Qiang Zhang · 2022 · PLoS ONE
  82. Coronavirus Disease-2019 in the Immunocompromised Host
    Christopher D. Bertini, Fareed Khawaja, Ajay Sheshadri · 2022 · Clinics in Chest Medicine
  83. The SARS-CoV-2 Spike Protein Activates the Epidermal Growth Factor Receptor-Mediated Signaling
    Abdul Rasheed Palakkott, Aysha Hamad Alneyadi, Khalid Muhammad, Ali Hussein Eid, Khaled M. A. Amiri, Mohammed Akli Ayoub, Rabah Iratni · 2023 · Vaccines
  84. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies
    Meryem Boutalaka, Salma El Bahi, Marwa Alaqarbeh, Moulay Ahfid El Alaouy, Yassine Koubi, Khalil El Khatabi, Hamid Maghat, Mohammed Bouachrıne, Tahar Lakhlifi · 2023 · Journal of Biomolecular Structure and Dynamics
  85. Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy
    Stephen W. Booth, John Willan, Henna Wong, Dalia Khan, Rachel Farnell, Alicia Hunter, Toby Andrew Eyre, Harley Katz, Moez Dungarwalla, Lucia Chen et al. · 2020 · European Journal Of Haematology
  86. Benign course of SARS‐CoV‐2 infection in a series of pediatric oncology patients
    Jenna E. Rossoff, Ami B. Patel, Emily Muscat, Larry K. Kociolek, William J. Muller · 2020 · Pediatric Blood & Cancer
  87. COVID-19 Testing in Patients with Cancer: Does One Size Fit All?
    Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, Rajat Kumar, Fei‐Fei Liu, Camilla Zimmermann, Shahid Husain, Gelareh Mohammed Zadeh, Amit M. Oza · 2020 · Clinical Cancer Research
  88. Management of cancer patients during COVID-19 pandemic at developing countries
    Jaime González‐Montero, Guillermo Valenzuela, Mónica Ahumada, Olga Barajas, Luis Villanueva · 2020 · World Journal of Clinical Cases
  89. Estimating the Risk of Death from COVID-19 in Adult Cancer Patients
    Matthew Williams, Emma Mi, Kerlann Le Calvez, Jiarong Chen, Lillie Pakzad-Shahabi, Seema Dadhania, J. Wang, Andrew Ho, Simon Rabinowicz · 2020 · Clinical Oncology
  90. Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort
    Talvinder Bhogal, Umair Khan, Rebecca J. Lee, Alexander J. Stockdale, Christian Hesford, Vaishnav Potti-Dhananjaya, Avith Jathanna, Shaun Rahman, Ann Tivey, Rohan Shotton et al. · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
  91. Technology-based health solutions for cancer caregivers to better shoulder the impact of COVID-19: a systematic review protocol
    Zhaohui Su, Dean McDonnell, Bin Liang, Jennifer Kue, Xiaoshan Austin Li, Sabina Šegalo, Shailesh Advani, Bertha E. Flores, Jing Wang · 2021 · Systematic Reviews
  92. More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study
    Caterina Monari, Caterina Sagnelli, Paolo Maggi, Vincenzo Sangiovanni, Fabio Giuliano Numis, Ivan Gentile, Alfonso Masullo, Carolina Rescigno, Giosuele Calabria, Matteo Megna et al. · 2021 · Frontiers in Oncology
  93. Postmortem high-dimensional immune profiling of severe COVID-19 patients reveals distinct patterns of immunosuppression and immunoactivation
    Haibo Wu, Peiqi He, Yong Ren, Shiqi Xiao, Wei Wang, Zhenbang Liu, Heng Li, Zhe Wang, Dingyu Zhang, Jun Cai et al. · 2022 · Nature Communications
  94. Cancer Occurrence as the Upcoming Complications of COVID-19
    Ilnaz Rahimmanesh, Laleh Shariati, Nasim Dana, Yasaman Esmaeili, Golnaz Vaseghi, Shaghayegh Haghjooy Javanmard · 2022 · Frontiers in Molecular Biosciences
  95. Factors affecting COVID‐19 vaccine hesitancy in parents of children with cancer
    Micah A. Skeens, Kylie N. Hill, Anna L. Olsavsky, Kimberly A. Buff, Jack H. Stevens, Terrah Foster Akard, Nilay Shah, Cynthia A. Gerhardt · 2022 · Pediatric Blood & Cancer
  96. Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways
    Aishwarya Jaiswal, Sanah Shrivastav, Hemant Ritturaj Kushwaha, Rupesh Chaturvedi, Rana Pratap Singh · 2024 · Cell Communication and Signaling
  97. Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak
    Marco Tagliamento, Francesco Spagnolo, Francesca Benedetta Poggio, Davide Soldato, Benedetta Conte, Tommaso Ruelle, Emanuela Barisione, Andrea De Maria, Lucia Del Mastro, Massimo Di Maïo et al. · 2020 · European Journal of Clinical Investigation
  98. Immune Correlates of COVID-19 Control
    B. Poonia, S. Kottilil · 2020 · Frontiers in Immunology
  99. Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease
    Sarju Ganatra, Sourbha S. Dani, Robert Allyn Redd, Kimberly Rieger‐Christ, Rushin P. Patel, Rohan B. Parikh, Aarti H. Asnani, Vigyan V. Bang, Katherine Shreyder, Simarjeet Brar et al. · 2021 · Journal of the National Comprehensive Cancer Network
  100. Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-Analysis
    Tung Hoang, Tho Thi Anh Tran · 2021 · Infection and Chemotherapy